BlueCrest Capital Management’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-44,917
| Closed | -$230K | – | 619 |
|
|
2019
Q3 | $230K | Hold |
44,917
| – | – | 0.02% | 443 |
|
|
2019
Q2 | $322K | Buy |
+44,917
| New | +$322K | 0.02% | 264 |
|
|
2018
Q4 | – | Sell |
-25,793
| Closed | -$286K | – | 1489 |
|
|
2018
Q3 | $286K | Buy |
+25,793
| New | +$286K | 0.01% | 1049 |
|
|
2018
Q2 | – | Sell |
-345,252
| Closed | -$4.49M | – | 1868 |
|
|
2018
Q1 | $4.49M | Buy |
+345,252
| New | +$4.49M | 0.14% | 133 |
|